Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate.
about
Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendationsCurrent management and prognostic features for gastrointestinal stromal tumor (GIST)UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST).Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal.Parametric images via dynamic 18F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumours.NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate.Characteristics of computed tomography imaging of gastrointestinal stromal tumor (GIST) and related diagnostic problems.Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelinesImatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors.Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group.Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECISTRecent advances and novel agents for gastrointestinal stromal tumor (GIST)Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors.Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment.Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to knowDiagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors.Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice.Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design.Gastrointestinal Stromal Tumors (GIST) and Their ManagementAssessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylateUpdate on Gastrointestinal Stromal Tumors for Radiologists.Response assessment in gastrointestinal stromal tumor.The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.Considering the role of radiation therapy for gastrointestinal stromal tumorPrognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors.Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor.Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review.Non-Gaussian diffusion imaging with a fractional order calculus model to predict response of gastrointestinal stromal tumor to second-line sunitinib therapy.Evaluation of Alterations in Tumor Tissue of Gastrointestinal Stromal Tumor (GIST) in Computed Tomography Following Treatment with Imatinib.The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST.The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use.Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q28247449-066F7250-18B4-43C6-ABF2-D144DD4B8D0BQ28391684-10106C3B-C7E3-40EA-9103-0E0B42D721B8Q33612778-AD05CDE4-CF8D-4BAC-B07C-0DBAE1F8B483Q33833577-D969E69D-0F23-4AF2-9476-89309FE198FAQ33844776-8AF7C1D5-90C5-4BEA-ADCF-D1C3D9F6C470Q33921067-761BC34F-88D1-4EA1-ADFC-E0BF50D43B8CQ34596126-FF12E6BF-BFA5-4663-9702-43C53CA6D62AQ34640458-0F2F9DD8-725F-4DD4-9037-574FC93F2A63Q34662946-BBB8711D-3EDA-4D9F-8864-1C04D7D1EAC6Q34672344-3C708A97-CBF4-4B87-9E6B-D159C48E0632Q35607790-47C6C941-E040-42D6-88E0-B8323B165848Q35996655-1066742F-6196-42D5-86DC-596E95182EB4Q36015295-5D3D525D-0F8E-44B5-A29E-41DE94D718EFQ36118178-953E067A-8791-4413-A900-D9A9B6BEB0F6Q36180074-B8904AFD-D968-4D13-8B34-B18E4B2EE8C4Q36426847-BA3DE3EC-7B61-40FD-86B0-298D2114F061Q36819466-55772C3F-23F3-4098-86E8-6981D7A52B6DQ36925163-0BF7C898-99C3-44EF-BAEB-691C611EFB40Q36971711-C9672ED6-8A54-4416-82BC-B674904C50BDQ37130325-08F694BA-3D26-4632-A9CA-051E29C4986BQ37153286-BB9EC4BA-6C6C-4485-A2A3-BB97C44FCCA4Q37203824-BCA4B17B-32F6-4A19-9C84-6D845DA0EF41Q37589533-193C78F6-15BA-48E3-8ECF-27DC66A32A8EQ37801348-F82C3430-5AD1-43B3-BF23-46009ABDB873Q38114042-17F6DDC9-2260-4925-9A83-46EAF0585E6DQ39754896-3A1DB982-2D5B-4265-A96B-0312A0E5B8D2Q41343422-074D4234-3A09-47AB-9A19-3E1467656DCFQ44247886-136C9CF4-6ADE-410A-BE4F-007B9A9B252EQ46738248-0D151C6D-AF64-4D63-A137-8541191E611AQ47097647-E688F456-C564-4612-85F1-B596F52C52D2Q48232138-6D687E10-D241-4573-BC75-FEDD1A48DEC5Q52587191-53776468-C519-4E92-862B-01870D98C28AQ54407986-5D984163-8CF4-4AC0-83E9-5E554044E4B6Q54485945-20362D2E-435F-4DD5-AEC9-1FF4EFA7C636Q57570640-4688E17B-DBCF-42C3-8BB1-C913C79458B7
P2860
Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Gastrointestinal stromal tumor ...... response to imatinib mesylate.
@ast
Gastrointestinal stromal tumor ...... response to imatinib mesylate.
@en
type
label
Gastrointestinal stromal tumor ...... response to imatinib mesylate.
@ast
Gastrointestinal stromal tumor ...... response to imatinib mesylate.
@en
prefLabel
Gastrointestinal stromal tumor ...... response to imatinib mesylate.
@ast
Gastrointestinal stromal tumor ...... response to imatinib mesylate.
@en
P2093
P1433
P1476
Gastrointestinal stromal tumor ...... response to imatinib mesylate.
@en
P2093
Annick Van Den Abbeele
Eric vanSonnenberg
George D Demetri
Jayesh Desai
Pamela J Dipiro
Sridhar Shankar
P304
P356
10.1148/RADIOL.2353040332
P407
P577
2005-04-15T00:00:00Z